U.S. Logistics Stock News

NasdaqGS:NEOG
NasdaqGS:NEOGMedical Equipment

What Neogen (NEOG)'s HYCOAT Recall for Contamination Concerns Means For Shareholders

In February 2026, Neogen Corporation announced a voluntary recall of all in-date lots of its Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution after microbial contamination was detected and adverse events were reported in horses, and the company is working with the FDA while its investigation continues. Management has emphasized that no adverse events have been linked to use strictly following the labeled directions, highlighting how product handling and administration practices may be...
NYSE:GPOR
NYSE:GPOROil and Gas

Gulfport Energy (GPOR) Profit Swing To US$396 Million Challenges Cautious Debt Narrative

Gulfport Energy (GPOR) has wrapped up FY 2025 with fourth quarter revenue of US$355.5 million and basic EPS of US$6.90, alongside net income excluding extra items of US$132.4 million. Over the past year, revenue on a trailing 12 month basis has moved from US$909.2 million in Q4 2024 to US$1.3 billion in Q4 2025, while basic EPS over the same window shifted from a loss of US$14.72 to a profit of US$21.74. This sets up a year in which margins and cash generation are front and center for...
NYSE:HHH
NYSE:HHHReal Estate

Is It Time To Reassess Howard Hughes Holdings (HHH) After Prolonged Share Price Weakness

If you are wondering whether Howard Hughes Holdings is starting to look like value at today's price, or if the market still sees it as a work in progress, this article will walk you through what the numbers are really saying. Despite trading at US$72.77, the stock has seen recent pressure, with returns of a 12.4% decline over 7 days, a 10.2% decline over 30 days, a 7.7% decline year to date and a 1.8% decline over the past year, extending to a 7.5% decline over 3 years and an 18.4% decline...
NasdaqGS:UTHR
NasdaqGS:UTHRBiotechs

United Therapeutics (UTHR) Net Margin Strength Reinforces Bullish Earnings Narrative

United Therapeutics (UTHR) FY 2025 Earnings Snapshot United Therapeutics (UTHR) closed FY 2025 with fourth quarter revenue of US$790.2 million and basic EPS of US$8.41, capping a twelve month run where trailing revenue reached US$3.2 billion and EPS came in at US$30.13. Over that period, revenue has moved from US$2.9 billion to US$3.2 billion and EPS has shifted from US$26.44 to US$30.13, giving investors a clear view of how the top line and EPS have tracked together. With a net income of...
NasdaqGS:REYN
NasdaqGS:REYNHousehold Products

Reynolds Consumer Products (REYN) Valuation Check After Product Of The Year Recognition

Reynolds Consumer Products and the 2026 Product of the Year win Reynolds Consumer Products (REYN) is back on investors’ radar after its Reynolds Kitchens Parchment Cooking Bags were voted the 2026 Product of the Year in the Kitchen Essentials category, based on feedback from 40,000 American shoppers. See our latest analysis for Reynolds Consumer Products. The Product of the Year recognition comes after a mixed spell for Reynolds Consumer Products, with a 7 day share price return of 2.8% and a...
NYSE:PEB
NYSE:PEBHotel and Resort REITs

Pebblebrook Hotel Trust Refinancing Resets Debt Timeline And Liquidity Options

Pebblebrook Hotel Trust (NYSE:PEB) recently completed a $450 million senior unsecured term loan. The company used part of the proceeds to repay certain mortgages and address near term debt maturities. Management also restored full capacity on its revolving credit facility, increasing available liquidity. Pebblebrook Hotel Trust, trading at $12.24, has had mixed share performance, with a 6.0% return year to date and a 4.6% return over the past year, but weaker 3 year and 5 year returns of...
NYSE:PERF
NYSE:PERFSoftware

Is It Time To Reassess Perfect (PERF) After A Multi Year Share Price Slump

If you are wondering whether Perfect's current share price reflects its true worth, this breakdown will help you connect the recent market action to what the numbers actually say about value. Perfect's share price closed at US$1.38, with returns of a 5.5% decline over 7 days, a 17.4% decline over 30 days, a 20.2% decline year to date, a 27.7% decline over 1 year and 81.9% and 86.1% declines over 3 and 5 years. This performance sits against a backdrop of ongoing market attention on software...
NYSE:MTDR
NYSE:MTDROil and Gas

Matador Resources (MTDR) Margin Compression Challenges Bullish Efficiency And Midstream Narratives

Matador Resources (MTDR) has wrapped up FY 2025 with fourth quarter revenue of US$848 million and basic EPS of US$1.55, alongside net income excluding extra items of US$192.5 million. This gives investors a clear read on its latest run rate. Over the past year, total revenue on a trailing twelve month basis has moved from US$3.24 billion in Q4 2024 to US$3.70 billion in Q4 2025, while trailing basic EPS shifted from US$7.16 to US$6.10, framing the current quarter against a fuller year of...
NasdaqGS:MGPI
NasdaqGS:MGPIBeverage

MGP Ingredients (MGPI) Trailing US$106.5m Loss Tests Bullish Margin Recovery Narratives

MGP Ingredients (MGPI) FY 2025 earnings snapshot MGP Ingredients (MGPI) has just wrapped up FY 2025 with fourth quarter revenue of US$138.3 million, Basic EPS of US$6.22 loss, and a net income loss excluding extra items of US$133.0 million. Over the past few quarters, the company has seen revenue move from US$161.5 million in Q3 FY 2024 to US$130.9 million in Q3 FY 2025 and EPS shift from US$1.07 in Q3 FY 2024 to US$0.71 in Q3 FY 2025, while trailing twelve month EPS moved from US$1.56 in Q4...
NYSE:KNTK
NYSE:KNTKOil and Gas

A Look At Kinetik Holdings (KNTK) Valuation After Recent Share Price Momentum And Conflicting Signals

Recent performance snapshot Kinetik Holdings (KNTK) has been drawing attention after a recent mix of short term and longer term share moves, including a 1.5% decline in the latest session and a 2.3% pullback over the past week. Over the past month the stock shows a 9.0% gain, while the past 3 months reflect a 28.5% return, alongside a 19.3% gain year to date and a 19.7% decline over the past year. See our latest analysis for Kinetik Holdings. The recent 9.1% 1 month share price return and...
NYSE:OKE
NYSE:OKEOil and Gas

ONEOK Earnings Growth And Dividend Raise Reshape Valuation And 2026 Outlook

ONEOK (NYSE:OKE) reported double digit net income and adjusted EBITDA growth for 2025. The company exceeded synergy targets from recent acquisitions, including Magellan, and retired a significant amount of long term debt. ONEOK raised its quarterly dividend by 4% and continued integrating acquired assets through 2025. Management outlined plans for 2026 that include expansion into fee based earnings and energy solutions for data centers. ONEOK is a large midstream operator focused on natural...
NYSE:NMM
NYSE:NMMShipping

Has The Market Fully Recognized Navios Maritime Partners (NMM) After Its Strong 12‑Month Rally?

If you are wondering whether Navios Maritime Partners is still attractively priced or already reflecting a lot of optimism, this article is here to break that question down into plain terms. The stock last closed at US$68.11, with returns of 5.5% over 7 days, 17.2% over 30 days, 32.5% year to date and 60.3% over the past year. That performance is likely to catch the eye of investors thinking about growth potential and changing risk perceptions. Recent news coverage around Navios Maritime...
NasdaqGS:UFPI
NasdaqGS:UFPIBuilding

UFP Industries (UFPI) Is Down 6.1% After Earnings Miss, Buybacks And Dividend Move - What's Changed

In February 2026, UFP Industries reported fourth-quarter 2025 sales of US$1,329.82 million and net income of US$39.96 million, both lower than a year earlier, while also completing a US$166.19 million share repurchase under its July 2025 authorization and declaring a quarterly dividend of US$0.36 per share. Amid softer earnings and cautious volume expectations, the company is pushing ahead with cost reductions and higher-value product launches such as Deckorators’ Surestone-based lines,...
NYSE:MATX
NYSE:MATXShipping

Matson (MATX) Q4 EPS Strength Tests Bearish Earnings Decline Narratives

Matson (MATX) has wrapped up FY 2025 with fourth quarter revenue of US$851.9 million and basic EPS of US$4.65, alongside full year trailing twelve month revenue of about US$3.3 billion and EPS of US$13.99. Over the past six reported quarters, revenue has moved between US$782 million and US$962 million, while quarterly EPS has ranged from US$2.20 to US$5.98, giving investors a clear view of how trading conditions have flowed through to the bottom line. With a trailing net margin of 13.3% and...
NYSE:CRCL
NYSE:CRCLSoftware

Circle Internet Group Q4 EPS Recovery Tests Bullish Profitability Narrative

Circle Internet Group (CRCL) just posted its FY 2025 Q4 numbers, with revenue of US$770.2 million and basic EPS of US$0.56, against a trailing twelve month revenue base of US$2.7 billion and basic EPS of US$0.44 loss. The company has seen quarterly revenue move from US$435.4 million in Q4 2024 to US$770.2 million in Q4 2025. Basic EPS shifted from US$0.08 in Q4 2024 through a volatile FY 2025 that included a US$4.48 loss in Q2 before settling at US$0.56 in Q4. This sets the stage for...
NYSE:AMP
NYSE:AMPCapital Markets

Assessing Ameriprise Financial (AMP) Valuation After Record Q4 2025 Earnings And Client Asset Highs

Ameriprise Financial (AMP) is in focus after reporting record fourth quarter 2025 earnings and client assets. The stock moved following results that reflected favorable markets, strong inflows, and increased analyst optimism. See our latest analysis for Ameriprise Financial. At a share price of $478.25, Ameriprise’s recent 1 day share price return of 2.58% clusters around the Q4 earnings release. However, the 30 day share price return of 4.45% and 1 year total shareholder return of a 7.77%...
NasdaqGM:FOLD
NasdaqGM:FOLDBiotechs

BioMarin Deal Reshapes Amicus Therapeutics Outlook For Growth And Portfolio

BioMarin Pharmaceutical has entered into a definitive agreement to acquire Amicus Therapeutics. The deal marks a major change for Amicus Therapeutics and its commercial portfolio. The transaction is viewed as a material event for shareholders and the wider biotechnology sector. For investors watching Amicus Therapeutics, NasdaqGM:FOLD, the new acquisition agreement with BioMarin comes at a time when the stock is trading at $14.34. Over the past year, the share price return of 58.8% and...
NYSE:HIPO
NYSE:HIPOInsurance

Hippo Holdings (HIPO) Combined Ratio Improvement Tests Bullish Profitability Narratives

Hippo Holdings FY 2025 Earnings: Profitability Backdrop Comes Into Focus Hippo Holdings (HIPO) has wrapped up FY 2025 with fourth quarter revenue of US$119.4 million, basic EPS of US$0.24 and net income of US$6 million, against a backdrop where trailing twelve month EPS sits at US$2.28 on revenue of US$467.6 million and net income of US$57.7 million. Over recent periods, the company has seen revenue move from US$101.9 million in Q4 2024 to US$119.4 million in Q4 2025, while quarterly basic...
NYSE:CWH
NYSE:CWHSpecialty Retail

Camping World Holdings (CWH) Q4 Loss Of US$67.3 Million Reinforces Bearish Profitability Narratives

Camping World Holdings FY 2025 Earnings Snapshot Camping World Holdings (CWH) has wrapped up FY 2025 with fourth quarter revenue of US$1.2 billion and a basic EPS loss of US$1.07, while trailing twelve month revenue came in at US$6.4 billion with a full year basic EPS loss of US$1.43. Over recent quarters the company has seen quarterly revenue range from US$1.4 billion to US$2.0 billion, with basic EPS moving from a profit of US$0.48 in Q2 2025 to losses in Q1, Q3 and Q4. This sets up a mixed...
NYSE:SWK
NYSE:SWKMachinery

Thin 2.7% Margin At Stanley Black & Decker (SWK) Tests Bullish Recovery Narrative

Stanley Black & Decker (SWK) closed out FY 2025 with Q4 revenue of US$3.7b and basic EPS of US$1.04 on net income of US$158.2m, setting the tone for how investors will read the full year. Over recent quarters, revenue has moved in a tight band between US$3.7b and US$3.9b, while quarterly EPS has ranged from US$0.34 to US$1.04, with trailing twelve month EPS at US$2.66 on revenue of US$15.1b. As a result, the focus now is on how efficiently those sales are turning into profit and what that...
NasdaqGS:COCO
NasdaqGS:COCOBeverage

Is It Too Late To Consider Coco (COCO) After A 63% One Year Surge?

If you are wondering whether Vita Coco Company stock is still attractively priced after a strong run, this article will walk through what the current market price might be implying about its value. The share price recently closed at US$55.07, with returns of 10.0% over 7 days, 0.4% over 30 days, 3.0% year to date and 63.4% over 1 year, while the 3 year return stands at 221.9%. Recent attention on Vita Coco has focused on its position in the branded coconut water and functional beverage...
NYSE:CVX
NYSE:CVXOil and Gas

Chevron (CVX) Margin Compression Challenges Bullish Profitability Narratives After Q4 Results

Chevron (CVX) closed out FY 2025 with fourth quarter revenue of US$45.1b and basic EPS of US$1.39, alongside trailing 12 month revenue of US$184.7b and EPS of US$6.65. Over recent quarters, revenue moved between US$44.5b and US$49.2b while quarterly EPS ranged from US$1.39 to US$2.49, giving investors a clear view of how the top line and per share earnings have tracked through the year. With net income of US$2.8b in the latest quarter and trailing 12 month profit of US$12.3b, the focus now...
NYSE:AAP
NYSE:AAPSpecialty Retail

Is Advance Auto Parts (AAP) Pricing Fully Reflecting Its Turnaround After Recent Share Rebound

If you are wondering whether Advance Auto Parts shares are now a bargain or still a value trap, this article walks through what the current price is really telling you. The stock recently closed at US$50.44, after a 9.8% decline over the last 7 days, a 6.1% gain over 30 days, a 29.7% gain year to date, a 36.9% gain over 1 year, but with 3 year and 5 year returns of 61.1% and 65.8% declines respectively. These moves sit against a backdrop of ongoing attention on the company’s turnaround...
NYSE:SCCO
NYSE:SCCOMetals and Mining

Is It Too Late To Consider Southern Copper (SCCO) After Its 146% One Year Rally?

If you are wondering whether Southern Copper's share price still offers value or if the easy gains are already behind it, you are in the right place. This article focuses on what the current price could mean for long term investors. The stock last closed at US$215.20, with returns of 11.7% over 7 days, 15.2% over 30 days, 46.0% year to date and 146.1% over the past year. This naturally raises questions about growth potential and how risk is now being priced in. Recent headlines around...